@article{2f7c9cf25e1b4920b84717a1f2886723,
title = "Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice",
keywords = "Cancer immunotherapy, Checkpoint inhibitors, Epigenetic therapy, Nucleic acid receptors, RIG-I",
author = "Hendrik Poeck and Alexander Wintges and Sarah Dahl and Florian Bassermann and Tobias Haas and Simon Heidegger",
note = "Funding Information: This study was supported by Deutsche Forschungsgemeinschaft–Projektnummer 360372040–SFB 1335 (to H.P. and F.B.) and 395357507–SFB 1371 (to H.P), a Mechtild Harf Research Grant (DKMS Foundation for Giving Life to H.P), European Research Commission (project BCM-UPS, grant #682473 to F.B.), a Young Investigator Award (Melanoma Research Alliance to S.H.), and Lady Tata Memorial Trust (to S.H.), the German Cancer Aid (111620) (to H.P. and S.H.), European Hematology Association (to H.P.). H.P. is supported by the EMBO Young Investigator Program. Open access funding enabled and organized by Projekt DEAL.",
year = "2021",
month = jun,
doi = "10.1002/eji.202049158",
language = "English",
volume = "51",
pages = "1531--1534",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",
}
